3D Cell Culture Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

3D cell culture refers to the process of growing cells in their native context or in vivo environment. Cells grown in 3D cell culture exhibit similar properties of cells found inside living organisms in terms of cellular characteristics and behavior. High prevalence of cancer along with increasing investment in research and development is expected to propel the market growth during the forecast period. Moreover, increasing focus on regenerative medicines is also expected to offer lucrative growth opportunities for players in the global 3D cell culture market.

Key features of the study:

• This report provides in-depth analysis of the Global 3D Cell Culture market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the Global 3D Cell Culture market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include, Becton, Dickinson and Company, Lonza Group, Thermo Fisher Scientific, Inc., Corning Incorporated, 3D Biotek LLC, 3D Biomatrix, Inc., Global Cell Solutions, Inc., InSphero AG, Sigma-Aldrich Corporation (a subsidiary of Merck KGaA), and Reinnervate Ltd. (a subsidiary of ReproCELL).
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The Global 3D Cell Culture market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global 3D Cell Culture market

Detailed Segmentation:

Global 3D Cell Culture Market, By Technology:

• Extracellular Matrices or Scaffolds
• Bioreactors
• Gels
• Scaffold-free platforms
• Microchips

Global 3D Cell Culture Market, By Application:

• Research
• Drug Discovery
• Tissue Engineering
• Clinical Applications
• Stem Cell Biology

Global 3D Cell Culture Market, By End User:

• Research Labs & Institutes
• Biopharmaceutical Industry
• Hospitals and diagnostic centers
• Others

Global 3D Cell Culture Market, By Region:

• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Country/Region
• South Africa
• Central Africa
• North Africa

Company Profiles

• Becton, Dickinson and Company *
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
• Lonza Group
• Thermo Fisher Scientific, Inc.
• Corning Incorporated
• 3D Biotek LLC
• 3D Biomatrix, Inc.
• Global Cell Solutions, Inc.
• InSphero AG
• Sigma-Aldrich Corporation (a subsidiary of Merck KGaA)
• Reinnervate Ltd. (a subsidiary of ReproCELL)
• “*” marked represents similar segmentation in other categories in the respective section.